Gen-t
PrivateLast Round
Grant
Jun 1, 2025
Total Funding Raised
$3.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Gen-t operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Grant round in June 2025.
Gen-t is a biotechnology company that develops a diverse genetic biobank to support genomic research and precision medicine in Brazil.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gen-t Comparables
Compare Gen-t with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omica Bio | 81% | |
| Galatea Bio Inc. | 79% | |
| UK Biobank | 73% |
For institutional investors. Book with your work email.
Gen-t Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2025 | ||||
| Pre Seed | Oct 15, 2024 | ||||
| Pre Seed | Sep 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gen-t Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 110% MoM.
- Jun 20, 2026
Monthly visitors increased 52% MoM.
For institutional investors. Book with your work email.
Gen-t Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gen-t's valuation, stock price, and market status.
Is Gen-t a public or private company?
Gen-t is a private company.
What is the current stock price of Gen-t?
Gen-t is a private company, so its shares have no public market price. Caplight tracks Gen-t's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gen-t worth (valuation)?
Valuation information for Gen-t is not publicly available.
Can I buy Gen-t stock?
Gen-t shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gen-t's last funding round?
Gen-t's most recent funding round was Grant on June 1, 2025.
Who are the main investors in Gen-t?
Key investors in Gen-t include FAPESP.
Will Gen-t IPO soon?
No public IPO plans have been announced for Gen-t.
How can I track Gen-t secondary market activity?
Caplight tracks bids, offers, and trades in Gen-t's shares on secondary markets.